The trading price of Sarepta Therapeutics Inc (NASDAQ:SRPT) floating lower at last check on Wednesday, June 26, closing at $155.52, -1.61% lower than its previous close.
The company’s P/E ratio in the trailing 12-month period was 2338.65. In examining the 52-week price action we see that the stock hit a 52-week high of $173.25 and a 52-week low of $55.25. Over the past month, the stock has gained 25.97% in value.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Sarepta Therapeutics Inc, whose market valuation is $14.70 billion at the time of this writing. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by 0.02 per share this quarter, however they have predicted annual earnings per share of 3.9 for current year and 13.02 for next year.
Analysts have forecast the company to bring in revenue of 396.17M for the current quarter, with the likely lows of 365.6M and highs of 463M. From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue is 2.02B.
On the technical side, indicators suggest SRPT has a 100% Buy on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Buy, while an average of long term indicators suggests that the stock is currently 100% Buy.
A quick review shows that SRPT’s price is currently 22.42% off the SMA20 and 22.28% off the SMA50. The RSI metric on the 14-day chart is currently showing 67.12, and weekly volatility stands at 5.70%. When measured over the past 30 days, the indicator reaches 4.78%. Sarepta Therapeutics Inc (NASDAQ:SRPT)’s beta value is currently sitting at 0.89, while the Average True Range indicator is currently displaying 8.30.
To see how Sarepta Therapeutics Inc stock has been performing today in comparison to its peers in the industry, here are the numbers: SRPT stock’s performance was -1.61% at last check in today’s session, and 43.63% in the past year. Sarepta Therapeutics Inc has a P/E ratio of 2338.65.
An evaluation of the daily trading volume of Sarepta Therapeutics Inc (NASDAQ:SRPT) indicates that the 3-month average is 1.68 million.
Currently, records show that 93.73 million of the company’s shares remain outstanding. The insiders hold 6.06% of outstanding shares, whereas institutions hold 87.24%. However, since the stock’s price has seen 61.28% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.
